The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland

BACKGROUND AND OBJECTIVE: Hyperkalaemia can be a life-threatening condition, particularly in patients with advanced chronic kidney disease with and without heart failure. Renin-angiotensin-aldosterone system inhibitor therapy offers cardiorenal protection in chronic kidney disease and heart failure;...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Thomas, Brown, Tray, Lewis, Ruth D., Kliess, Melodi Kosaner, de Arellano, Antonio Ramirez, Quinn, Carol M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440184/
https://www.ncbi.nlm.nih.gov/pubmed/35925491
http://dx.doi.org/10.1007/s41669-022-00357-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440184/
https://www.ncbi.nlm.nih.gov/pubmed/35925491
http://dx.doi.org/10.1007/s41669-022-00357-z

Ejemplares similares